Related Experiment Videos
Type-specific pneumococcal respiratory disease in the elderly and chronically III
The American Review of Respiratory Disease
|February 1, 1978
Summary
Pneumococcal respiratory disease in a chronic-disease hospital showed that vaccine types were common in pneumonia and chronic bronchitis cases. Vaccination may benefit elderly and chronically ill patients against pneumococcal pneumonia.
Area of Science:
- Medical Microbiology
- Infectious Diseases
- Public Health
Background:
- Pneumococcal respiratory disease poses a significant health burden, particularly in vulnerable populations.
- Understanding the prevalence of specific pneumococcal serotypes is crucial for effective prevention strategies.
Purpose of the Study:
- To investigate the types of pneumococcal bacteria causing respiratory infections in a chronic-disease hospital.
- To assess the potential impact of pneumococcal vaccination on disease control in this setting.
Main Methods:
- A 27-month study involving isolates from 50 pneumonia patients and 24 chronic bronchitis patients.
- Serotype identification of Streptococcus pneumoniae isolates.
- Analysis of isolate types against current vaccine formulations.
Main Results:
- Vaccine-targeted pneumococcal serotypes were identified in 74% of pneumonia cases and 42% of chronic bronchitis cases.
- Serotypes from patients with bacteremia and fatalities were also vaccine-included.
- A high proportion of severe pneumococcal infections involved vaccine-type strains.
Conclusions:
- Pneumococcal vaccination could theoretically reduce pneumonia incidence in closed populations of elderly and chronically ill individuals.
- The benefit of vaccination for patients with chronic bronchitis requires further investigation.
- Targeted vaccination strategies may be effective in controlling pneumococcal pneumonia in high-risk groups.